Name: Dr Conni McCarthy
Qualifications: B.Sc Biochemistry, M.Sc. Biochemistry, Dr. sc. ETH Zurich
Position: George Holt Fellow in Ocular Oncology Research
E-mail: [email protected]
Phone: 0151 794 9123
Address:
Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
University of Liverpool
6th Floor, Duncan Building
Daulby Street
Liverpool
L69 3GA
Research Interests:
Almost half of the UM patients will develop metastases, which usually involve the liver. Since current treatments for metastatic UM are ineffective, the mortality of UM patients with metastatic disease remains high. The lack of effective therapies for metastatic UM patients drives the urgent need for improved knowledge of the molecular drivers of metastasis and, ultimately, the identification of new drug targets. Therefore my research interests lie in the characterisation of these hepatic lesions by use of high resolution molecular genetic methods.
Key projects:
Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets.
Publications:
Insights into genetic alterations of liver metastases from uveal melanoma.
McCarthy C, Kalirai H, Lake SL, Dodson A, Damato BE, Coupland SE.
Pigment Cell Melanoma Res. 2016 Jan;29(1):60-7. doi: 10.1111/pcmr.12433.
Qualifications: B.Sc Biochemistry, M.Sc. Biochemistry, Dr. sc. ETH Zurich
Position: George Holt Fellow in Ocular Oncology Research
E-mail: [email protected]
Phone: 0151 794 9123
Address:
Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
University of Liverpool
6th Floor, Duncan Building
Daulby Street
Liverpool
L69 3GA
Research Interests:
Almost half of the UM patients will develop metastases, which usually involve the liver. Since current treatments for metastatic UM are ineffective, the mortality of UM patients with metastatic disease remains high. The lack of effective therapies for metastatic UM patients drives the urgent need for improved knowledge of the molecular drivers of metastasis and, ultimately, the identification of new drug targets. Therefore my research interests lie in the characterisation of these hepatic lesions by use of high resolution molecular genetic methods.
Key projects:
Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets.
Publications:
Insights into genetic alterations of liver metastases from uveal melanoma.
McCarthy C, Kalirai H, Lake SL, Dodson A, Damato BE, Coupland SE.
Pigment Cell Melanoma Res. 2016 Jan;29(1):60-7. doi: 10.1111/pcmr.12433.
